Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05023265Not ApplicableRecruiting

Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT

Role: collaborator

NCT01542216Not ApplicableWithdrawn

Evaluation of Nutrition and Metabolism in Breast Cancer Patients

Role: collaborator

NCT01599182Completed

Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer

Role: collaborator

All 3 trials loaded